UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010795
Receipt number R000012607
Scientific Title Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions
Date of disclosure of the study information 2013/05/23
Last modified on 2018/06/20 23:18:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions

Acronym

Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions

Scientific Title

Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions

Scientific Title:Acronym

Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions

Region

Japan


Condition

Condition

Benign or malignant pulmonary lesions

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the usefulness of the navigation system Directpath in bronchoscopy for pulmonary peripheral lesions.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Diagnostic yield

Key secondary outcomes

Directpath
The bronchial generation order allowing automatic virtual image production
The bronchial generation order for which manual registration is added

Bronchoscope
Consistency with virtual images
The bronchial generation order allowing insertion and the outer diameter of the bronchus on virtual images
The distance from the bronchoscope insertion site to the lesion and the number of bronchial divisions
The bronchial generation order allowing observation
The bronchial generation order allowing observation

Diagnostic yield
Diagnostic yields according to the method and bronchoscope used
Diagnostic yield according to the lesion size
Diagnostic yields according to the distance between the lesion and hilum
Diagnosis yields according to the lesion visualization rate using ultrasound, whether the lesion is visualized, and the positional relationship between the ultrasound probe and lesion Visibility on EBUS.
Diagnostic yield according to location of probe in relation to target lesion

Examination time

Safety, Complications


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Virtual images toward pulmonary peripheral lesions are produced using Directpath.
Transbronchial biopsy (TBB) with virtual bronchoscopic navigation (VBN) is performed using a 2.8-mm ultrathin bronchoscope (BF-XP260F; channel inner diameter, 1.2 mm; Olympus). Subsequently, endobronchial ultrasound-guided transbronchial biopsy (EBUS-TBB) /transbronchial needle aspiration (TBNA) with VBN is performed using a 4.0-mm bronchoscope (BF-P260F, inner diameter of the operation channel, 2.0 mm; Olympus).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. On chest CT images, an abnormal shadow is present in the peripheral area of the lung field, and bronchoscopy is necessary to make a diagnosis or determine treatment principles
2. 20 years of age or older
3. Consent in writing to participate in this study has been obtained from patients themselves

Key exclusion criteria

1. Case with serious concomitant medical illness
2. Central pulmonary lesions
3. Diffuse pulmonary lesions
4. Re-examination due to prior failure in this trial
5. Case with pure ground glass opacity
6. Patients needing to undergo other bronchoscopic procedures (e.g. TBNA, BAL)
7. Bleeding tendency
8. Pregnant woman
9. Other clinical difficulties in this trial

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Fumihiro Asano

Organization

Gifu Prefectural General Medical Center

Division name

Department of Pulmonary Medicine and Bronchoscopy

Zip code


Address

4-6-1, Noishiki, Gifu, Japan

TEL

058-246-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Akifumi Tsuzuku

Organization

Gifu Prefectural General Medical Center

Division name

Department of Pulmonary Medicine and Bronchoscopy

Zip code


Address

4-6-1, Noishiki, Gifu, Japan

TEL

058-246-1111

Homepage URL


Email

a.tsuzuku@gmail.com


Sponsor or person

Institute

Gifu Prefectural General Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岐阜県総合医療センター(岐阜県)


Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 23 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 23 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 23 Day

Last follow-up date

2013 Year 11 Month 30 Day

Date of closure to data entry

2013 Year 12 Month 31 Day

Date trial data considered complete

2013 Year 12 Month 31 Day

Date analysis concluded

2014 Year 05 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 05 Month 23 Day

Last modified on

2018 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012607


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name